Position in EXEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,181,973
-$197,903 QoQ
Shares Held
167,451
-0.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,584 across 78 Biotechnology names. EXEL ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
167,451 | $7,181,973 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,181,973 | 167,451 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,379,876 | 168,375 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,558,926 | 231,451 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $9,611,864 | 218,055 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $8,246,192 | 223,353 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,004,154 | 240,365 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,442,719 | 286,810 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,044,627 | 224,505 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,073,776 | 171,672 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,408,641 | 225,454 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,115,784 | 234,132 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,273,703 | 223,637 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,896,580 | 252,271 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,105,887 | 255,978 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,352,431 | 213,803 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $3,883,053 | 171,286 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,912,826 | 159,345 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,118,192 | 147,502 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,216,535 | 121,654 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,729,007 | 120,806 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,589,170 | 129,007 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,547,279 | 145,083 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $3,637,371 | 153,217 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,719,571 | 157,931 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||